Clinical Trials Logo
  1. Home
  2. Covid19
  3. NCT04382417
  4. Details
NCT04382417 Clinical Trial

Prospective Observational Cohort Study of Critically Ill Patients With Covid-19 in Sweden

Covid-19 Clinical Trial

Official title:
Characteristics and Outcomes of Critically Ill Patients With Covid-19 in a Large Swedish County Hospital - a Prospective Observational Cohort Study

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04382417
Other study ID # RegionVastmanland
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 26, 2020
Est. completion date November 12, 2020

Study information
Verified date March 2021
Source Region Västmanland
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study will prospectively collect data from patients with Covid-19 admitted to the Västerås Intensive Care Unit, Västerås Hospital. Demographic, clinical, radiographic and laboratory characteristics will be recorded. Analysis of data to identify predictors of disease severity, mortality and treatment response.

Recruitment information / eligibility
Status Completed
Enrollment 57
Est. completion date November 12, 2020
Est. primary completion date November 12, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients admitted to the Intensive Care Unit with biological samples positive for SARS-CoV-2. - Patients admitted to the Intensive Care Unit with one or more negative tests but with clinical and radiological characteristics highly suggestive of SARS-CoV-2 and thus considered positive for the disease. Exclusion Criteria: - None.

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Observational study
Not required

Locations
Country Name City State
Sweden Intensive Care Unit, Västerås Hospital Västerås Västmanland

Sponsors (1)
Lead Sponsor Collaborator
Region Västmanland

Country where clinical trial is conducted

Sweden, 

Outcome
Type Measure Description Time frame Safety issue
Primary All-cause mortality At 90 days follow-up after admittance to Intensive Care
Secondary Hospital length of stay Until 90 days after admittance to Intensive Care
Secondary ICU length of stay Until 90 days after admittance to Intensive Care
Secondary Number of days on mechanical ventilation Until 90 days after admittance to Intensive Care
Secondary Number of patients receiving vasopressor support Until 90 days after admittance to Intensive Care
Secondary Number of patients receiving renal replacement therapy Until 90 days after admittance to Intensive Care
Secondary Patient characteristics At admission to ICU
See also
  Status Clinical Trial Phase
Withdrawn NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Completed NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure